T he allowable storage time for platelets has been maintained at 5 days in the United States to reduce the risk of fatal and nonfatal septic reactions from bacterially contaminated blood components. 1 The Council of Europe 2 also recommends storage of 5 days, which can be extended to 7 days if a validated system is used to assure the absence of bacterial contamination such as that implemented by Schelstraete and colleagues. 3 AuBuchon 4 has proposed increasing the allowable shelf life of room temperature stored platelets from 5 to 7 days as a means to recover costs associated with a bacterial screening program and to relieve platelet inventory pressures. Acceptable in vivo performance of 7-day platelets was recently reported. 5, 6 The objective of this study was to determine the allowable storage configuration determined by volume, platelet concentration, and total platelets within a particular platelet storage bag (COBE ELP, Gambro BCT, Lakewood, CO).
METHODS
This study was conducted under approval of the Colorado Multi-Institutional Review Board. Apheresis platelets were collected from volunteer subjects (n = 20) with an apheresis system (COBE Spectra LRS Turbo, version 7, Gambro BCT, Denver, CO). Subjects met standard FDA and AABB donation criteria and reported no consumption of any medications known to alter platelet function or antibiotics within the 7 days before platelet donation. Platelet concentration and volume per bag were controlled to examine a wide combination of these variables, as shown in Fig. 1 . Platelets in plasma were stored in one ELP bag composed of PVC plasticized with N-butyryltrin-hexyl citrate at 22ЊC with horizontal agitation in a temperature-controlled platelet incubator (Helmer PC3200, Helmer Laboratories, Inc., Noblesville, IN) for 8 days. 7 Component volume was determined gravimetrically with a density correction factor of 1.03 g per mL. Samples for analysis were removed aseptically by swabbing the sampling site coupler with a 1 percent iodine-saturated pad and then inserting a sterile needle with syringe. Residual WBCs on day of collection (Day 0) were counted with a WBC enumeration system (LeucoCOUNT, BD Immunocytometry Systems, San Jose, CA) on a flow cytometer (FACScan, BD Immunocytometry Systems). On Days 0, 1, 2, 5, 7, and 8, platelet count was measured with an automated hematology analyzer (Serono Baker 9018 + CP, BioChem Immunosystems, Allentown, PA); component pH at 22ЊC (pH 22ЊC ), pO 2 , and pCO 2 , with a blood gas analyzer (Ciba Corning 238, Norwood, MA) within 4 minutes of sampling; and glucose and lactate, with a chemistry autoanalyzer (YSI 2700 Select, YSI, Inc., Yellowsprings, OH). Bicarbonate content was calculated for 22ЊC with standard formulae. 8 Extent of shape change (ESC) and hypotonic shock response (HSR) were measured on Days 1, 5, and 7 according to the methods of Holme et al. 9 (SPA2000, Chronolog Corporation, Havertown, PA). Morphology (Days 1, 5, and 7) was determined after the method of Kunicki et al., 10 reporting a summary score with a maximum of 400. Platelet surface-expressed P-selectin (Days 1, 5, and 7) was determined with a double labeling method on a FACScan following the procedure of Dumont et al. 11 Two antibodies were utilized: CD61-FITC to identify all platelets and CD62-PE (BD Immunocytometry Systems) to identify activated platelets expressing surface P-selectin. Oxygen consumption was directly measured in a closed 37ЊC water-jacketed chamber with a Clarktype electrode (oxygen meter Model 781, oxygen electrode Model 1302, Strathkelvin Instruments, Bearsden, Glasgow, Scotland) on Days 1, 5, and 7.
12 All components were cultured on Day 7 in aerobic medium (BacT/ALERT SA, Organon Teknika, Durham, NC) and monitored for a minimum of 7 days in an automated detection system (BacT/ALERT 3D, Organon Teknika). Data were recorded with clock time (hours and minutes), but are reported here for convenience in days of storage.
Statistical analysis
Output variables were analyzed as independent univariate responses in a mixed-effects ANOVA or mixed-effects multivariate linear regression model. The full model was built to include all main and interaction effects of Group (1-4) and day of storage (1) (2) (3) (4) (5) (6) (7) . Platelet bag and day were included in the model as random effects. The repeated measures correlation within a subject was included in the covariance structure. The final model used for hypothesis testing was determined with a stepdown approach where terms of the full model not contributing to the fit to the data were removed. The validity of removing these terms was evaluated with a likelihood ratio test and minimizing the Akaike information criteria, two methods of evaluating goodness of fit. In vitro platelet characteristics were reported with summary statistics. All hypothesis tests were conducted at ␣ = 0.05. All calculations and plotting were performed with computer software (SAS System for Windows v. 8.01, SAS Institute, Cary, NC; or Excel 2000, Mi- 
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crosoft Corporation, Redmond, WA) on a personal computer. (Fig. 1) . The current ELP bag storage limit recommendations per bag are shown by the broken line in Fig. 1 (100-400 mL, 1 ‫ן‬ 10 6 -2.1 ‫ן‬ 10 6 platelets/L, maximum 5.1 ‫ן‬ 10 11 platelets). 13 Five of 24 components with platelet concentrations greater than 2.1 ‫ן‬ 10 6 were outside the current recommended range to permit evaluation of an extended platelet concentration limit. Six of the remaining 19 were less than 1 percent beyond these margins on Day 0. Components were categorized into four groups by the total number of platelets per bag for analysis, as described in Fig. 1 Table 2) .
RESULTS

Twenty
In platelet components, the generation of lactic acid from glycolysis is the predominant acid source and cause of pH 22ЊC fall over the storage period.
14 Glucose consumption and lactate production are linear over 8 days (Table 3) . Groups 2 and 4 were within historical ranges for apheresis platelets in the ELP bag (30- lactic acid production up to 468 mol per 10 12 platelets per hour under completely anaerobic conditions. This is in agreement with studies by this laboratory (L.J. Dumont, unpublished observations). Bicarbonate levels fell steadily for all groups over the 7-day storage.
O 2 consumption over 7 days was generally stable ( Table 2 ). All groups and components were able to utilize O 2 throughout the 7-day storage, suggesting, in conjunction with the lactate data, that the capacity for oxidative phosphorylation was maintained.
In vitro activation, indicated by a loss in morphology score and increases in surface-associated P-selectin, is shown in Table 4 . Groups 3 and 4 showed equivalent Group 1 morphology departed from Group 2 after Day 5, dropping to 256 ‫ע‬ 10 on day 7. For P-selectin expression, again Groups 1 and 2 were equivalent (ndf = 1, ddf = 37, F = 0.5, p = 0.4841), and Groups 3 and 4 were equivalent (ndf = 1, ddf = 37, F = 0.88, p = 0.3534). Day 7 estimated levels of P-selectin expression were (estimate ‫ע‬ SE) 42.2 ‫ע‬ 2.6 percent for combined Groups 1 and 2 and 24.5 ‫ע‬ 2.3 percent for combined Groups 3 and 4. Groups 2 and 3 had equivalent HSRs over the 7-day storage period (ndf = 1, ddf = 37, F = 0.01, p = 0.9421). They had no change from Day 1 to Day 5, but dropped to a combined 53.0 ‫ע‬ 2.77 percent (mean ‫ע‬ SE) by day 7. Groups 1 and 4 showed steady decline in HSR over 7 days, 2.4 ‫ע‬ 0.5 and 0.82 ‫ע‬ 0.40 percent per day, respectively. ESC initial levels and rate of decline over 7 days were significantly different between each group. The lowest drop was 0.79 percent per day for Group 4, and the highest drop was 1.68 percent per day for Group 3. platelets/bag). Therefore, we conclude that the most likely cause of poor storage for this one unit is related to a peculiarity of this component and that it is not indicative of the general performance characteristics of the platelet bag or storage conditions. Platelet activation, indicated by morphology and Pselectin expression, consistently increased over the storage period. Kunicki et al. 10 observed a correlation of platelet morphology with recoveries in transfusion to thrombocytopenic patients. We observed a decline of up to 6.4 points per day with a Day 7 mean of 256 for Group 1, a change of 12 percent from Day 5. While difficult to compare absolute values across laboratories and time, these values are similar to morphology of 208 observed by Bertolini et al. 15 in Day 5 platelet-rich plasma (PRP)-prepared platelets in plasma.
P-selectin expression indicates the degree of release of ␣-granule content by the platelets. There have been conflicting data regarding the role of P-selectin in in vivo outcomes. Holme et al. 16 and Dumont et al. 6 observed the recovery and survival of autologous platelet transfusions to healthy volunteers correlate with P-selectin expression. Triulzi et al. 17 observed an inverse relationship between P-selectin expression and 1-hour CCIs in thrombocytopenic oncology patients. However, Michelson et al. 18 concluded that methods that evaluate soluble Pselectin may be of more value clinically than platelet surface P-selectin expression for evaluating circulation of degranulated platelets. We saw a mean Day 7 value of 42.2 percent for Groups 3 and 4, which compares favorably to values reported by Holme et al. 16 of 33 percent to 51 percent for Day 5 platelets prepared on apheresis instruments (MCS, Haemonetics, Braintree, MA; Spectra; and CS-3000, Baxter Healthcare Corporation, Fenwal, Deerfield, IL).
Holme et al. 9 suggested that HSR and ESC may be indicators of in vivo recoveries. We observed a steady decline in all groups over 7 days for ESC, with Group 3 reaching 13.2 percent on Day 7. This level is similar to 15 ‫ע‬ 3 percent from Holme et al. 19 for 0.5-day-old PRPprepared platelets. HSR declined over storage with Group 1 reaching 53.1 percent on Day 7. Again this level is not different from the 59 and 44 percent observed in the same study by Holme et al. 19 for PRP-prepared platelets by Days 5 and 7, respectively.
Metabolic function of the platelets was shown by lactate production, glucose consumption, and the capacity of the platelet to utilize O 2 throughout the storage period. The platelets maintained their ability to utilize oxygen throughout the 7 days of storage as shown by O 2 consumption rates. Lactate generation, although different between groups, was consistent over 7 days. Lactate generation reached approximately 15 percent of the 468 mol per 10 12 platelets per hour observed under fully anaerobic conditions, suggesting that adequate oxygen was present during the storage interval.
In spite of the vast amount of research conducted on platelet activation in vitro, there is no perfect correlation between in vitro function measures and in vivo efficacy. The surrogate test for platelet function and efficacy has remained recovery and survival of transfused platelets in normal donors and thrombocytopenic patients. 20 The functional range of pH has long been recognized as an important factor for storage. Figure 3 summarizes platelet recoveries versus pH for several of the historical studies plus more recent studies conducted with platelets stored in ELP bags. 6, 21, 22 Low pH was observed in 1 of 24 components in this study. Platelet concentrates reaching low pH during storage have been associated with poor recovery and survival of radiolabeled platelets in transfusions to healthy volunteers. Murphy and others 23, 24 have reported on the poor in vivo platelet recoveries if the pH value drops below 6.2. In vitro data suggest some measurable effects on platelets at pH 6.2-6.8, [25] [26] [27] [28] although these effects seem to be reversed when the platelets are maintained at 37ЊC and physiologic pH. 29, 30 The majority of components in this study (16/24 or 67%) exceeded pH 7.4 at some time during storage. Higher pH values have also been associated with poor recoveries, although results are confounded with platelet agitator type (Fig. 3) . The Council of Europe Recommendation states:
Generally, acceptable storage is obtained when . . . the pH of the platelet product stays continuously between 6.8 and 7.4 under the storage period used. Improved platelet bags and optimized conditions for the preparation and storage of platelets may result in acceptable in vivo post transfusion recovery also at . . . pH values below 6.8 or above 7.4 as validated. 31 There are no upper limits imposed from a regulatory or community standards position in North America, although there are often questions on this issue.
Platelets in storage present a complex respiratory and buffering system. The volatile bicarbonate buffering, acid production, CO 2 permeability of the container, and fuel source selected by the platelets are quite dynamic. 24 This system only occasionally reaches steady state, but at the same time must maintain pH within an acceptable range. The initial pH, 7.0-7.3, is determined primarily by the whole blood to anticoagulant ratio during apheresis and the Hct of the donor. Over the next 24 to 48 hours, 
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the platelet bag loses CO 2 until the rate of loss from the bag more closely approximates the rate of production from metabolic sources. The component pH then begins to decline. The literature evidence to support an upper pH limit is vague, and the effects on the platelet may be strongly dependent on the precise conditions under which the platelets are stored (e.g., type of agitator). In vitro observations of platelet responses suggest that several modifications in response and platelet characteristics may be seen at higher pH: morphology, 28 LDH release, 26 blunted ADP response, 32 increased ADP and collagen response, 33 and increased response to concanavalin A. 34 Murphy and Gardner 29 noted that in vivo recoveries began to decline when the pH value is greater than 7.2 for components stored with a Ferris-wheel-type agitator. In a later study, Murphy et al. 35 again found that in vivo recoveries dropped at pH values greater than 7.5 when stored on an elliptical agitator. These data are presented in Fig. 3 along with 91 transfusions from platelets collected on Gambro apheresis systems and stored in the ELP bag. There seems to be a clear drop in the recovery of platelets below pH 6.1-6.2 for both flat-bed agitators and an aliquot mixer (Ames Lab-Tek). Above pH 7.1-7.2 a detrimental effect is also seen for components stored on elliptical and Ferris-wheel-type agitators. In sharp contrast to these results are those shown for the ELP bag with mean recoveries of 61.9 percent (NB: these are raw recoveries and not a percentage of control platelets). The ELP components were stored on a flat-bed-type agitator. Also, it should be noted that while the ELP components shown in Fig. 3 have only the Day 5 or Day 7 pH values indicated, it is expected that they transitioned through an even higher pH over the course of storage. Hunter et al., 36 in a recent report on the effect of the interruption of agitation during storage, showed good HSR and ESC for platelets with pH 6.6-7.7 after 5 days of storage. Again, these data reinforce the potential role of agitator type, perhaps synergistically with pH.
The constraint of continuously maintaining a pH value below 7.4 is not in concert with the current state of the art in platelet bag technology. The pH profile of stored platelets in current bags, such as the ELP bag, is much different from that seen in early generations having low gas transmission. As shown in Fig. 2 , it is common for platelet components to transition through a higher pH when stored in current state-of-the-art bags. QC monitoring of platelet components is often conducted on the day of issue from the blood center, typically Day 1 or Day 2. This is the period when one would expect the pH to be close to its maximum, as shown in Fig. 2 , and not a good indicator of the final pH at the end of storage. In this study, platelets at or above pH 7.4 were not damaged.
The data presented in this study show, as expected, a gradual and continuing decline in platelet in vitro characteristics over storage through Day 7. Metabolic function of the platelets was maintained, and the pH 22ЊC value was greater than 6.2. These data suggest some expected reduction in survival and recovery of 7-day platelets when compared with 5-day components. These findings are supported by a recent in vivo autologous transfusion study that found a 14 and 17 percent reduction in recovery and survival, respectively. 6 These small changes, while significant, are in line with current standard of care for transfused platelet components. These data support the fact that extension of platelet storage in plasma in the ELP bag maintains platelet function adequate for transfusion. These data further support an acceptable storage configuration for the ELP bag of 100 to 400 mL per bag, 1.0 ‫ן‬ 10 6 to 2.5 ‫ן‬ 10 6 platelets per L, and a maximum of 5.1 ‫ן‬ 10 11 platelets per bag.
